The good companions: insulin and glucagon-like peptide-1 receptor agonist in type 2 diabetes. A systematic review and meta-analysis of randomized controlled trials

This publication has 56 references indexed in Scilit:

• A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (BEGIN: VICTOZA ADD‐ON)
  Diabetes, Obesity and Metabolism, 2014
• Glycemic control among patients with type 2 diabetes who initiate basal insulin: a retrospective cohort study
  Journal of Medical Economics, 2013
• Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled With Newly Initiated and Continuously Titrated Basal Insulin Glargine
  Diabetes Care, 2013
• Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity
  Cardiovascular Diabetology, 2012
• Sequential Intensification of Metformin Treatment in Type 2 Diabetes With Liraglutide Followed by Randomized Addition of Basal Insulin Prompted by A1C Targets
  Diabetes Care, 2012
• Randomized, double‐blind, placebo‐controlled trial of the once‐daily GLP ‐1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea ( GetGoal ‐L‐Asia)
  Diabetes, Obesity and Metabolism, 2012
• Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes
  Annals of Internal Medicine, 2011
• Insulin initiation in primary care for patients with type 2 diabetes: 3-Year follow-up study
  Primary Care Diabetes, 2010
• The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
  Journal of Clinical Epidemiology, 2009
• A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes
  Diabetologia, 2008